Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder

Neuropsychobiology

Volumn 48, Issue 3, 2003, Pages 111-115

  Maayan, Rachel ^a   Yoran Hegesh, Roni ^a,b   Strous, Rael ^a,c   Nechmad, Allon ^a   Averbuch, Elena ^b   Weizman, Abraham ^a,d   Spivak, Baruch ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b NESS ZIONA MENTAL HEALTH CENTER   (Israel)

^c BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

^d GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Attention deficit hyperactivity disorder; Dehydroepiandrosterone; Dehydroepiandrosterone sulfate; Methylphenidate; Neurosteroids

Indexed keywords

BOLDENONE; HYDROCORTISONE; METHYLPHENIDATE; PRASTERONE; PRASTERONE SULFATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GABAERGIC SYSTEM; HORMONE BLOOD LEVEL; HUMAN; MALE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RATING SCALE; SCHOOL CHILD; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE; TIME PERCEPTION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; HUMANS; MALE; METHYLPHENIDATE; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0242299667     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073626     Document Type: Article

References (41)

1. Carrey NJ, Wiggins DM, Milin RP: Pharmacological treatment of psychiatric disorders in children and adolescents: Focus on guidelines for the primary care practitioner. Drugs 1996;51:750-759.
2. Elia J, Ambrosini PJ, Rapoport JL: Treatment of attention-deficit- hyperactivity disorder. N Engl J Med 1999;11:780-788.
3. Rapport MD, Stoner G, DuPaul GJ, Kelly KL, Tucker SB, Schoeler T: Attention deficit disorder and methylphenidate: A multilevel analysis of dose-response effects on children's impulsivity across settings. J Am Acad Child Adolesc Psychiatry 1988;27:60-69.
4. Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, Pollack S: Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry 1997;54:1073-1780.
5. Van der Meere J, Shalev R, Borger N, Gross-Tsur V: Sustained attention, activation and MPH in ADHD: A research note. J Child Psychol Psychiatr 1995;36:697-703.
6. Douglas VI, Barr RG, Desilets J, Sherman E: Do high doses of stimulants impair flexible thinking in attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 1995;34:877-885.
7. Whalen CK, Henker B, Granger DA: Social judgment processes in hyperactive boys: Effects of methylphenidate and comparisons with normal peers. J Abnorm Child Psychol 1990;18:297-316.
8. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R, Pappas N: Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 1998;155:1325-1331.
9. Hurd YL, Ungerstedt U: In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur J Pharmacol 1989;166:251-260.
10. Butcher SP, Liptrot J, Aburthnott GW: Characterization of methylphenidate- and nomifensine-induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci Lett 1991;122:245-248.
11. 3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus. J Pharmacol Exp Ther 1979;210:422-428.
12. Solanto MV: Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behav Brain Res 1998;94:127-152.
13. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG: Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999;283:397-401.
14. Challman TD, Lipsky JJ: Methylphenidate: Its pharmacology and uses. Mayo Clin Proc 2000;75:711-721.
15. Baulieu EE, Robel P: Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA-S) as neuroactive neurosteroids. Proc Natl Acad Sci USA 1998;95:4089-4091.
16. Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu EE: Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA 1981;78:4704-4707.
17. Cascio C, Prasad VV, Lin YY, Lieberman S, Papadopoulos V: Detection of P450c17-independent pathways for dehydroepiandrosterone (DHEA) biosynthesis in brain glial tumor cells. Proc Natl Acad Sci USA 1998;95:2862-2867.
18. Majewska MD: Neurosteroids: Endogenous bimodal modulators of the GABA-A receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992;38:379-395.
19. Wolf OT, Kirschbaum C: Actions of dehydroepiandrosterone and its sulfate in the central nervous system: Effects on cognition and emotion in animals and humans. Brain Res Brain Res Rev 1999;30:264-288.
20. Schlegel ML, Spetz JF, Robel P, Haug M: Studies on the effects of dehydroepiandrosterone and its metabolites on attack by castrated mice on lactating intruders. Physiol Behav 1985;34:867-870.
21. Flood JF, Morley JE, Roberts E: Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci USA 1992;89:1567-1571.
22. Flood JF, Smith GE, Roberts E: Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 1988;447:269-278.
23. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E: Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 1999;156:646-649.
24. Strous RD, Spivak B, Yoran-Hegesh R, Maayan R, Averbuch E, Kotler M, Mester R, Weizman A: Analysis of neurosteroid levels in attention deficit hyperactivity disorder. Int J Neuropsychopharmacol 2001;4:259-264.
25. Conners CK, Russell A, Barkley R: Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 1985;21:809-815.
26. Spivak B, Vered Y, Yoran-Hegesh R, Averbuch E, Mester R, Graf E, Weizman A: Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder. Acta Psychiatr Scand 1999;99:300-304.
27. Majewska MD: Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect. Ann NY Acad Sci 1995;774:111-120.
28. Murray HE, Gillies GE: Differential effects of neuroactive steroids on somatostatin and dopamine secretion from primary hypothalamic cell cultures. J Neuroendocrinol 1997;9:287-295.
29. Robel P, Baulieu EE: Neurosteroids: Biosynthesis and function. Crit Rev Neurobiol 1995;9:383-394.
30. Zinder O, Dar DE: Neuroactive steroids: Their mechanism of action and their function in the stress response. Acta Physiol Scand 1999;167:181-188.
31. Young J, Corpechot C, Perche F, Eychenne B, Haug M, Baulieu EE, Robel P: Neurosteroids in the mouse brain: Behavioral and pharmacological effects of a 3beta-hydroxysteroid dehydrogenase inhibitor. Steroids 1996;61:144-149.
32. Imamura M, Prasad C: Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem Res Commun 1998;243:771-775.
33. Bitran D, Dugan M, Renda P, Ellis R, Foley M: Anxiolytic effects of the neuroactive steroid pregnanolone (3alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Res 1999;11:217-224.
34. Herbert J: Neurosteroids, brain damage, and mental illness. Exp Gerontol 1998;33:713-727.
35. van Goozen SH, Matthys W, Cohen-Kettenis PT, Thijssen JH, van Engeland H: Adrenal androgens and aggression in conduct disorder prepubertal boys and normal controls. Biol Psychiatry 1998;43:156-158.
36. Tirelli E, Geter-Douglass B, Witkin JM: Gamma-aminobutyric acidA agonists differentially augment gnawing induced by indirect-acting dopamine agonists in C57BL/6J mice. Pharmacol Exp Ther 1998;284:116-124.
37. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci USA 1995;92:3774-3778.
38. Svec F, Porter J: The effect of dehydroepian-drosterone (DHEA) on Zucker rat food selection and hypothalamic neurotransmitters. Psychoneuroendocrinology 1997;22(suppl 1):S57-S62.
39. Bergeron R, de Montigny C, Debonnel G: Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: Effects mediated via sigma receptors. J Neurosci 1996;16:1193-1202.
40. Oranje B, van Berckel BN, Kemner C, van Ree JM, Kahn RS, Verbaten MN: The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology 2000;22:293-302.
41. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ: Genetic enhancement of learning and memory in mice. Nature 1999;401:63-69.